Synthesis and structure -: Activity relationship studies of 3,6-diazabicyclo[3.2.0]heptanes as novel α4β2 nicotinic acetylcholine receptor selective Agonists

被引:37
|
作者
Ji, Jianguo
Schrimpf, Michael R.
Sippy, Kevin B.
Bunnelle, William H.
Li, Tao
Anderson, David J.
Faltynek, Connie
Surowy, Carol S.
Dyhring, Tino
Ahring, Philip K.
Meyer, Michael D.
机构
[1] Nuerosci Res, Abbott Pk, IL 60064 USA
[2] NeuroSearch A S, Ballerup, Denmark
关键词
D O I
10.1021/jm070755h
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of novel, potent neuronal nicotinic acetylcholine receptor (nAChR) ligands derived from 3,6-diazabicyclo[3.2.0]heptane have been synthesized and evaluated for binding affinity and agonist activity at the alpha 4 beta 2 nAChR subtype. Structure- activity relationship studies of these novel nAChR ligands focused on substitution effects on the pyridine ring, as well as stereo- and regiochemical influences of the 3,6-diazabicyclo[3.2.0]heptane core. Small 5-substituents on the pyridine ring had a modest impact on the binding affinities and functional activities. 6-Bromo, 6-chloro, and 6-methyl substituents on the pyridine ring led to increased binding affinities and improved functional activities. Most of the 6-N-pyridinyl -substituted 3,6-diazabicyclo[3.2.0]heptanes are selective for the alpha A beta 2 nAChR subtype. Compounds (IR,5S)-25, (I R,5S)55, and (I R,5S)-56 were virtually inactive as agonists at the h alpha 3 beta 4 nAChR but retained potency and efficacy at the h alpha 4 beta 2 nAChR subtype. 3-N-Pyridinyl-substituted series demonstrated more complex SAR. (IR,5R)39, (1R,5R)-41, and (IR,5R)-42 were found to be much more potent at the h alpha 3 beta 4.nAChR subtype, whereas (IR,5R)-38 and (JR,5R)-40 were very selective at the h alpha 4 beta 2 nAChR subtype. The SAR studies of these novel ligands led to the discovery of several compounds with interesting in vitro pharmacological profiles.
引用
收藏
页码:5493 / 5508
页数:16
相关论文
共 50 条
  • [21] Discovery, synthesis, and structure activity of a highly selective α7 nicotinic acetylcholine receptor antagonist
    Whiteaker, Paul
    Christensen, Sean
    Yoshikami, Doju
    Dowell, Cheryl
    Watkins, Maren
    Gulyas, Jozsef
    Rivier, Jean
    Olivera, Baldomero M.
    McIntosh, J. Michael
    BIOCHEMISTRY, 2007, 46 (22) : 6628 - 6638
  • [22] Design, Synthesis, and Evaluation of Novel 3,6-Diaryl-4-aminoalkoxyquinolines as Selective Agonists of Somatostatin Receptor Subtype 2
    Wolkenberg, Scott E.
    Zhao, Zhijian
    Thut, Catherine
    Maxwell, Jill W.
    McDonald, Terrence P.
    Kinose, Fumi
    Reilly, Michael
    Lindsley, Craig W.
    Hartman, George D.
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (07) : 2351 - 2358
  • [23] Synthesis and structure-activity relationship of 3-arylbenzoxazines as selective estrogen receptor β agonists
    Yang, W
    Wang, YF
    Ma, ZP
    Golla, R
    Stouch, T
    Seethala, R
    Johnson, S
    Zhou, R
    Güngör, T
    Feyen, JHM
    Dickson, JK
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (09) : 2327 - 2330
  • [24] Structure Activity Relationship Studies toward the Discovery of Selective Apelin Receptor Agonists
    Margathe, Jean-Francois
    Iturrioz, Xavier
    Alvear-Perez, Rodrigo
    Marsol, Claire
    Riche, Stephanie
    Chabane, Hadjila
    Tounsi, Nassera
    Kuhry, Maxime
    Heissler, Denis
    Hibert, Marcel
    Llorens-Cortes, Catherine
    Bonnet, Dominique
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (07) : 2908 - 2919
  • [25] Selective α4β2 Nicotinic Acetylcholine Receptor Agonists Target Epigenetic Mechanisms in Cortical GABAergic Neurons
    Ekrem Maloku
    Bashkim Kadriu
    Adrian Zhubi
    Erbo Dong
    Fabio Pibiri
    Rosalba Satta
    Alessandro Guidotti
    Neuropsychopharmacology, 2011, 36 : 1366 - 1374
  • [26] Selective α4β2 Nicotinic Acetylcholine Receptor Agonists Target Epigenetic Mechanisms in Cortical GABAergic Neurons
    Maloku, Ekrem
    Kadriu, Bashkim
    Zhubi, Adrian
    Dong, Erbo
    Pibiri, Fabio
    Satta, Rosalba
    Guidotti, Alessandro
    NEUROPSYCHOPHARMACOLOGY, 2011, 36 (07) : 1366 - 1374
  • [27] Novel Acetylcholine and Carbamoylcholine Analogues: Development of a Functionally Selective α4β2 Nicotinic Acetylcholine Receptor Agonist
    Hansen, Camilla P.
    Jensen, Anders A.
    Christensen, Jeppe K.
    Balle, Thomas
    Lijefors, Tommy
    Frolund, Bente
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (23) : 7380 - 7395
  • [28] Synthesis and activity of substituted carbamates as potentiators of the α4β2 nicotinic acetylcholine receptor
    Springer, Stephanie K.
    Woodin, Katrina S.
    Berry, Virginia
    Boezio, Alessandro A.
    Cao, Lei
    Clarkin, Kristie
    Harmange, Jean-Christophe
    Hierl, Markus
    Knop, Johannes
    Malmberg, Annika B.
    McDermott, Jeff S.
    Nguyen, Hung Q.
    Waldon, Daniel
    Albrecht, Brian K.
    McDonough, Stefan I.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (20) : 5643 - 5647
  • [29] Agonists at the α4β2 nicotinic acetylcholine receptors:: Structure-activity relationships and molecular modelling
    Tonder, JE
    Olesen, PH
    CURRENT MEDICINAL CHEMISTRY, 2001, 8 (06) : 651 - 674
  • [30] Design, Synthesis and Discovery of Picomolar Selective α4β2 Nicotinic Acetylcholine Receptor Ligands
    Yenugonda, Venkata M.
    Xiao, Yingxian
    Levin, Edward D.
    Rezvani, Amir H.
    Thao Tran
    Al-Muhtasib, Nour
    Sahibzada, Niaz
    Xie, Teresa
    Wells, Corinne
    Slade, Susan
    Johnson, Joshua E.
    Dakshanamurthy, Sivanesan
    Kong, Hye-Sik
    Tomita, York
    Liu, Yong
    Paige, Mikell
    Kellar, Kenneth J.
    Brown, Milton L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (21) : 8404 - 8421